Clinical Trials

NCT04285671 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
30 participants

Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2021-01-29
Completion:
2026-12-02
Conditions
  • Metastatic Lung Non-Small Cell Carcinoma
  • Refractory Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8
  • Stage IVA Lung Cancer AJCC v8
  • Stage IVB Lung Cancer AJCC v8
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
No Results Yet
NCT04230109 | RECRUITING | PHASE2
239 participants

Sacituzumab Govitecan In TNBC

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2020-07-14
Completion:
2028-10-31
Conditions
  • Invasive Breast Cancer
  • Triple Negative Breast Cancer
  • ER-Negative Breast Cancer
  • PR-Negative Breast Cancer
  • HER2-negative Breast Cancer
Interventions
  • DRUG
No Results Yet
NCT03938324 | COMPLETED | NA
222 participants

Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2019-10-29
Completion:
2024-06-19
Conditions
  • Sickle Cell Disease
  • Chronic Kidney Diseases
  • Systemic Lupus Erythematosus
  • Childhood Cancer
  • Inflammatory Bowel Diseases
  • Stem Cell Transplant
  • Organ Transplant
  • Diabetes Mellitus, Type 1
  • Cystic Fibrosis
Interventions
  • BEHAVIORAL
NCT03480360 | COMPLETED | PHASE3
21 participants

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2018-03-28
Completion:
2025-02-14
Conditions
  • Acute Myeloid Leukemia
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • Myelodysplasia
  • Myeloproliferative Disorder
  • Myelofibrosis
  • Lymphoma
  • Lymphoma, Non-Hodgkin
  • Plasma Cell Disorder
Interventions
  • DRUG
  • RADIATION
  • PROCEDURE
NCT02740634 | RECRUITING | NA
60 participants

Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2016-05-31
Completion:
2027-03-31
Conditions
  • Atypical Alzheimer's Disease
  • Logopenic Progressive Aphasia (LPA)
  • Posterior Cortical Atrophy (PCA)
  • Alzheimer Disease
  • Alzheimer Disease, Early Onset
  • Amnestic Disorder
  • Amnestic Symptoms
  • Amnestic Mild Cognitive Disorder
Interventions
  • DRUG
No Results Yet
NCT02721732 | ACTIVE_NOT_RECRUITING | PHASE2
157 participants

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2016-08-15
Completion:
2028-12-31
Conditions
  • Advanced Malignant Solid Neoplasm
  • Carcinoma of Unknown Primary
  • Metastatic Adrenal Gland Pheochromocytoma
  • Metastatic Kidney Medullary Carcinoma
  • Metastatic Malignant Germ Cell Tumor
  • Metastatic Malignant Solid Neoplasm
  • Metastatic Paraganglioma
  • Metastatic Penile Carcinoma
  • Metastatic Skin Squamous Cell Carcinoma
  • Small Cell Carcinoma
  • Stage III Adrenal Cortex Carcinoma AJCC v7
  • Stage IV Adrenal Cortex Carcinoma AJCC v7
  • Stage IV Penile Cancer AJCC v7
  • Stage IV Renal Cell Cancer AJCC v7
  • Unresectable Adrenal Gland Pheochromocytoma
  • Unresectable Paraganglioma
  • Unresectable Skin Squamous Cell Carcinoma
  • Unresectable Solid Neoplasm
  • Vascular Neoplasm
Interventions
  • OTHER
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page